Article thumbnail

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

By Jeroen Witteveldt, Matthew J. Evans, Julia Bitzegeio, George Koutsoudakis, Ania M. Owsianka, Allan G. N. Angus, Zhen-Yong Keck, Steven K. H. Foung, Thomas Pietschmann, Charles M. Rice and Arvind H. Patel

Abstract

Hepatitis C virus (HCV) infects cells by the direct uptake of cell-free virus following virus engagement with specific cell receptors such as CD81. Recent data have shown that HCV is also capable of direct cell-to-cell transmission, although the role of CD81 in this process is disputed. Here, we generated cell culture infectious strain JFH1 HCV (HCVcc) genomes carrying an alanine substitution of E2 residues W529 or D535 that are critical for binding to CD81 and infectivity. Co-cultivation of these cells with naïve cells expressing enhanced green fluorescent protein (EGFP) resulted in a small number of cells co-expressing both EGFP and HCV NS5A, showing that the HCVcc mutants are capable of cell-to-cell spread. In contrast, no cell-to-cell transmission from JFH1ΔE1E2-transfected cells occurred, indicating that the HCV glycoproteins are essential for this process. The frequency of cell-to-cell transmission of JFH1W529A was unaffected by the presence of neutralizing antibodies that inhibit E2–CD81 interactions. By using cell lines that expressed little or no CD81 and that were refractive to infection with cell-free virus, we showed that the occurrence of viral cell-to-cell transmission is not influenced by the levels of CD81 on either donor or recipient cells. Thus, our results show that CD81 plays no role in the cell-to-cell spread of HCVcc and that this mode of transmission is shielded from neutralizing antibodies. These data suggest that therapeutic interventions targeting the entry of cell-free HCV may not be sufficient in controlling an ongoing chronic infection, but need to be complemented by additional strategies aimed at disrupting direct cell-to-cell viral transmission

Topics: Jgv Direct
Publisher: Society for General Microbiology
OAI identifier: oai:pubmedcentral.nih.gov:2885024
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
  2. (2006). A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels.
  3. (2008). Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus.
  4. (2002). Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.
  5. (2007). Bidirectional membrane molecule transfer between dendritic and T cells.
  6. (2008). Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein.
  7. (2004). CD81 is an entry coreceptor for hepatitis C virus.
  8. (1993). Concurrent analysis of intracellular glutathione content and gap junctional intercellular communication.
  9. (2000). Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
  10. (2008). Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies.
  11. (2008). Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
  12. (2006). Gap junctional intercellular communication and cytoskeletal organization in chondrocytes in suspension in an ultrasound trap.
  13. (2008). Hepatitis C virus entry into host cells.
  14. (2008). Hepatitis C virus entry.
  15. (2006). hepatitisC virusE2 epitope defined by the broadly neutralizing monoclonal antibody AP33.
  16. (2002). Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.
  17. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap.
  18. (2000). Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.
  19. (2008). Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein.
  20. (2006). Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.
  21. (2003). Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes.
  22. (2004). Intercellular communication and human hepatocellular carcinoma.
  23. (2005). Kissing-loop interaction in the 39 end of the hepatitis C virus genome essential for RNA replication.
  24. (2005). Liver cell lines for the study of hepatocyte functions and immunological response.
  25. (2007). Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.
  26. (2005). Monoclonal antibody CD81 is dispensable for cell-to-cell transport of HCV http://vir.sgmjournals.org 57AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.
  27. other authors (2005). Complete replication of hepatitis C virus in cell culture.
  28. other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
  29. other authors (2006). A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.
  30. other authors (2006). Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact.
  31. other authors (2008). Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.
  32. other authors (2008). Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
  33. (1998). Restored gap junctional communication in non-tumorigenic HeLanormal human fibroblast hybrids.
  34. (2004). Retroviral spread by induction of virological synapses.
  35. (2007). Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission.
  36. (2001). Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient.
  37. (2007). The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
  38. (2007). The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses.
  39. (2006). Time- and temperaturedependent activation of hepatitis C virus for low-pH-triggered entry.
  40. (1997). Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee.